Boston, MA -- (SBWIRE) -- 12/06/2013 -- At winstonsmallcap.com we focus on undervalued companies trading under $5. Right now the markets are surging and we are seeing an opportunity in micro-cap companies like we have never seen before. Let have a Look on: URANIUM PARTC CORP (OTCMKTS:URPTF), ProPhotonix Ltd (OTCMKTS:STKR), STELLAR BIOTECH INC (OTCMKTS:SBOTF), Lion Biotechnologies Inc (OTCMKTS:LBIO)
URANIUM PARTC CORP (OTCMKTS:URPTF) increased 0.21% at the price of $5.16 recently on a traded volume of 118,905.00 shares, in comparison to 43,329.00 shares of average trading volume. So far this year, the stock is down over -4.72%.
The company has a total market capitalization of $-4.72 million. Uranium Participation Corporation operates as an investment holding company. The company invests its assets substantially in uranium oxide in concentrates (U3O8). U3O8 is primarily used as a fuel for nuclear power plants.
For How Long URPTF will Fight for Profitability? Read This Trend Analysis report
ProPhotonix Ltd (OTCMKTS:STKR) soared 88.24% at the trading price of $0.0320 on a traded volume of 1.42 million shares till now, whereas its average trading volume is 44,111.00 shares. In the last three months, the stock is up 75.29%. The Intra-day range for the stock is $0.01 and $0.04. ProPhotonix Limited (ProPhotonix) designs and manufactures light emitting diode (LED) illumination solutions, as well as produces laser modules. The Company operates in two segments.
For How Long STKR Gloss will Attract Investors? Find out via this report
STELLAR BIOTECH INC (OTCMKTS:SBOTF) jumped up 1.67% at the $1.83 recently. So far in three months, the stock is up 42.97%. The 52-week range for the stock is $0.23 and $2.30. Its introductory price for the day was $1.86, with the overall traded volume of 60,704.00 shares. Stellar Biotechnologies, Inc. produces and markets keyhole limpet hemocyanin (KLH), as well as develops technology related to the culture and production of KLH and subunit KLH formulations in the United States and Europe.
Will SBOTF Continue To Move Higher? Find Out Here
Lion Biotechnologies Inc (OTCMKTS:LBIO) after opening its shares at the price of $10.45, jumped up 7.69% , its recent trading price was $11.20 for the day. The stock moved on a traded volume of 21,526.00 shares, in comparison to 27,800.00 shares of average trading volume.
The 52-week range for the stock is $1.01 and $31.50. Its introductory price for the day was $10.45. Lion Biotechnologies, Inc., formerly Genesis Biopharma, Inc. is a development-stage company. The Company is a biotechnology company focused on developing and commercializing adoptive cell therapy using autologous tumor infiltrating lymphocytes for the treatment of stages IV metastatic melanoma and other cancers.
Why Should Investors Buy LBIO After The Recent Gain? Just Go Here and Find Out
Here at Winston we focus on undervalued companies trading under $5. Right now the markets are surging and we are seeing an opportunity in micro-cap companies like we have never seen before. We focus on companies that we feel are trading at a discount to the market for various reasons. Enter your email and track our performance! We are sure you won’t be disappointed.
http://winstonsmallcap.com/ and its owners, and their affiliates, directors and officers, and immediate family members, are hereafter collectively referred to as “WSC” or “we” or “us” or “our”). WSC publishes information (the “Information”) about publicly traded companies (the “Profiled Company” or the “Profiled Companies”) which has been obtained from various sources including publicly available sources on the internet. WSC does not undertake any due diligence or investigation of the Information it obtains or publishes.
Read Full Disclaimer at: http://winstonsmallcap.com/disclaimer
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)